FDA Clearance Tracker · P050053-S015
INFUSE BONE GRAFT
Last checked: Nov 20, 2026Latest source record: Jul 24, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Jul 24, 2014
Approved
Time to decision
1,532 days
Received May 14, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P050053-S015
- Device name
- INFUSE BONE GRAFT
- Applicant
- Medtronic, Inc.
- Applicant location
- Memphis, TN
- Received
- May 14, 2010
- Decided
- Jul 24, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P050053
Device type
- Device class
- Class III
- Regulation
- 21 CFR 872.3930
- Specialty
- Dentistry & Oral Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT WYETH FARMA, S.A, IN DE LOS REYES, SPAIN.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.